These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 3344655)

  • 1. Thromboxane synthetase inhibition reduces ventricular irritability after coronary occlusion and reperfusion.
    Austin JC; Berrizbeitia LD; Schoen FJ; Kauffman RP; Hechtman HB; Cohn LH
    Am Heart J; 1988 Mar; 115(3):505-9. PubMed ID: 3344655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravenous infusion of a selective inhibitor of thromboxane A2 synthetase in man: influence on thromboxane B2 and 6-keto-prostaglandin F1 alpha levels and platelet aggregation.
    Yui Y; Hattori R; Takatsu Y; Nakajima H; Wakabayashi A; Kawai C; Kayama N; Hiraku S; Inagawa T; Tsubojima M
    Circulation; 1984 Oct; 70(4):599-605. PubMed ID: 6434196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of selective thromboxane synthetase inhibitor OKY-046 on plasma prostaglandins in patients with coronary artery disease during exercise.
    Shikano M; Ogawa K; Ito T; Chen LS; Ito Y; Imaizumi M; Uno T; Tsutsumi S; Satake T
    Adv Prostaglandin Thromboxane Leukot Res; 1985; 13():375-7. PubMed ID: 3159226
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of a selective thromboxane synthetase inhibitor (OKY-046) in patients with coronary artery disease during exercise.
    Shikano M; Ito T; Ogawa K; Satake T
    Jpn Heart J; 1987 Sep; 28(5):663-74. PubMed ID: 3323562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective effect of a novel thromboxane synthetase inhibitor, CV-4151, on myocardial damage due to coronary occlusion and reperfusion in the hearts of anesthetized dogs.
    Imamoto T; Terashita Z; Tanabe M; Nishikawa K; Hirata M
    J Cardiovasc Pharmacol; 1986; 8(4):832-9. PubMed ID: 2427826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of OKY-046, a selective thromboxane synthetase inhibitor, on blood pressure and thromboxane synthesis in spontaneously hypertensive rats.
    Gomi T; Ikeda T; Ishimitsu T; Uehara Y
    Prostaglandins Leukot Essent Fatty Acids; 1989 Sep; 37(3):139-44. PubMed ID: 2608692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of an experimental model of acute myocardial infarction and the effects of a thromboxane synthetase inhibitor (OKY-046).
    Tomoda H
    Am Heart J; 1986 Oct; 112(4):696-704. PubMed ID: 3532743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of OKY-046, a selective thromboxane A2 synthetase inhibitor, on ventricular arrhythmias and prostaglandins during coronary artery ligation and reperfusion in anesthetized dogs.
    Ogura T; Watanabe I; Saito T; Saito S; Ozawa Y; Hatano M
    Jpn J Pharmacol; 1988 May; 47(1):95-8. PubMed ID: 3411822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of a thromboxane A2 synthetase inhibitor on ventricular fibrillation threshold during coronary artery occlusion and reperfusion.
    Toda I; Nozaki A; Kawakubo K; Murakawa Y; Inoue H; Yoshimoto N; Sugimoto T
    Jpn Heart J; 1990 Jan; 31(1):87-97. PubMed ID: 2335849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of thromboxane synthetase inhibitors (OKY-046, OKY-1580) on experimentally induced air embolism in anesthetized dogs.
    Ishihara Y; Uchida Y; Kitamura S
    Prostaglandins Leukot Med; 1986 Feb; 21(2):197-206. PubMed ID: 3457388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of the new class I antiarrhythmic agent Ro 22-9194, (2R)-2-amino-N-(2,6-dimethylphenyl)-N-[3-(3-pyridyl)propyl]propionamide D-tartrate, on ischemia- and reperfusion-induced arrhythmias in dogs: involvement of thromboxane A2 synthase inhibitory activity.
    Murakami M; Kinukawa M; Kanazawa T; Maruyama K; Miyagi M; Miyata H; Ujiie A
    J Pharmacol Exp Ther; 1996 Nov; 279(2):877-83. PubMed ID: 8930195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Beneficial effect of a selective TXA2 synthetase inhibitor, OKY-046, both on thromboxane B2 production and vascular damage after spinal cord injury in rat spinal cord].
    Morimoto K; Ikata T; Tounai T
    Nihon Seikeigeka Gakkai Zasshi; 1990 Jan; 64(1):82-8. PubMed ID: 2319197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of OKY-1581, a thromboxane synthetase inhibitor, on coronary thrombosis in the conscious dog.
    Shea MJ; Driscoll EM; Romson JL; Pitt B; Lucchesi BR
    Eur J Pharmacol; 1984 Oct; 105(3-4):285-91. PubMed ID: 6542526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thromboxane synthetase inhibitors reduce infarct size by a platelet-dependent, aspirin-sensitive mechanism.
    Mullane KM; Fornabaio D
    Circ Res; 1988 Apr; 62(4):668-78. PubMed ID: 3127073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of a thromboxane synthetase inhibitor (OKY-046) in an ischemia-reperfusion model of intrauterine growth retardation in Sprague-Dawley rats.
    Tanaka M; Natori M; Ishimoto H; Miyakoshi K; Miyazaki T; Kobayashi T; Yoshimura Y
    Biol Neonate; 1997; 72(3):181-6. PubMed ID: 9303217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulmonary vascular response to thrombin: effects of thromboxane synthetase inhibition with OKY-046 and OKY-1581.
    Garcia-Szabo R; Kern DF; Malik AB
    Prostaglandins; 1984 Dec; 28(6):851-66. PubMed ID: 6543018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of selective thromboxane synthetase inhibitor and indomethacin on prostacyclin and thromboxane A2 from ischemic canine heart.
    Ogawa K; Sakai K; Ito T; Watanabe J; Satake T
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():371-6. PubMed ID: 6221548
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of thromboxane A2 synthetase inhibitor on metabolism and contractility in ischemic reperfused rabbit heart.
    Kawabata H; Ryomoto T; Katori R
    Angiology; 1997 Aug; 48(8):689-97. PubMed ID: 9269138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of OKY-046 (thromboxane A2 synthetase inhibitor) on exercise-induced asthma.
    Hoshino M; Fukushima Y
    J Asthma; 1991; 28(1):19-29. PubMed ID: 1849133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical study on effect of thromboxane A2 synthetase inhibitor (OKY-046) to clarify the regulation of cerebral blood flow in cerebral thrombosis.
    Nihei C; Metoki H; Shimanaka Y; Kawahara R; Komatsu O; Oike Y; Kanazawa T; Izawa M; Kaneko H; Hoshi Y
    Adv Prostaglandin Thromboxane Leukot Res; 1987; 17B():953-7. PubMed ID: 2960210
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.